Global Viral Vector Vaccines Market Size By Type (Adeno-Associated Virus (AAV), Lentivirus), By Disease (Cancer, Genetic Disorders), By End-Users (Research Institutes, Pharmaceutical And Biopharmaceutical Companies), By Geographic Scope And Forecast
Report ID: 37152|No. of Pages: 202
Global Viral Vector Vaccines Market Size By Type (Adeno-Associated Virus (AAV), Lentivirus), By Disease (Cancer, Genetic Disorders), By End-Users (Research Institutes, Pharmaceutical And Biopharmaceutical Companies), By Geographic Scope And Forecast
Viral Vector Vaccines Market Size And Forecast
Viral Vector Vaccines Market size was valued at USD 2.29 Billion in 2023 and is projected to reach USD 6.00 Billion by 2030, growing at a CAGR of 21.65% from 2024 to 2030.
The market is fueled by the rising incidence of genetic disorders, cancer, and infectious diseases, as well as by the rising number of clinical trials, funding for the development of gene therapies, and potential uses for novel drug delivery systems. The Global Viral Vector Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Viral Vector Vaccines Market Definition
Live viruses are transported into human cells using viral vector vaccines. The virus’s DNA was also used to produce antigenic proteins as the basis for various immune responses. The live attenuated virus used in this type of vaccine has been genetically altered to carry DNA-encoding protein antigens from an unrelated organism. The viral vector is intentionally produced and examined for immunotherapeutic and vaccine applications. Vaccinia virus vectors, the fowlpox virus, attenuated yellow fever, adenovirus, and others are different viral vector vaccines. End-users like Clinics, Hospitals, and Other Institutions make use of them.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37152
Global Viral Vector Vaccines Market Overview
Over the years, the market is anticipated to be driven by rising rates of chronic diseases like cancer, HIV, tuberculosis, and cardiovascular diseases. Additionally, the market is anticipated to grow in the upcoming years due to the rise in the elderly population and technological developments in producing viral vectors.
Additionally, rising cost-effective treatments and the biopharmaceutical industries’ growing use of viral vectors are anticipated to fuel market expansion during the anticipated time frame. There are some limitations and difficulties that can impede market expansion. Poor reimbursement infrastructure and high vaccine costs are two factors that could limit market expansion. The rise in genetic disorders and infectious diseases also impacts the growth of viral vector production.
Global Viral Vector Vaccines Market: Segmentation Analysis
The Global Viral Vector Vaccines Market is Segmented on the basis of Type, Disease, End-Users, and Geography.
Viral Vector Vaccines Market, By Type
- Adeno-associated virus (AAV)
- Lentivirus
- Adenovirus
- Retrovirus
- Others
Based on Type, The market is segmented into Adeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, and Others. The Adeno-associated virus (AAV) segment is anticipated to dominate the Global Viral Vector Vaccines Market due to their low pathogenicity and toxicity, capacity to infect both dividing and non-dividing cells, and long-term transgene expression profiles, adeno-associated virus (AAV) vectors have been widely used in gene therapy applications. Additionally, the safety record across several clinical trials has been favorable.
Viral Vector Vaccines Market, By Disease
- Cancer
- Genetic Disorders
- Infectious Diseases
- Others
Based on Disease, The market is segmented into Cancer, Genetic Disorders, Infectious Diseases, and Others. Its significant market share can be attributed to the development of viral vector gene therapies for cancer.
Viral Vector Vaccines Market, By End-Users
- Research Institutes
- Pharmaceutical and Biopharmaceutical Companies
Based on End-Users, The market is segmented into Research Institutes and Pharmaceutical and Biopharmaceutical Companies. This can be attributed to the significant contributions made by the international research community to the creation of cutting-edge therapies for managing several genetic and acquired diseases for which there was previously no efficient paradigm of care.
Viral Vector Vaccines Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the world
On the basis of Geography, the Global Viral Vector Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America will hold the largest Viral Vector Vaccines Market share. The primary driving force behind the region’s dominance is the rapidly increasing number of advanced therapy products entering clinical trials and the presence of vital operating players in the area.
Key Players
The “Global Viral Vector Vaccines Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Advanced Bioscience Laboratories, C.H. Boehringer Sohn AG & Ko, Sanofi S.A., Brammer Bio, LLC, Creative Biogene, GE Healthcare, and Pfizer Inc.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Viral Vector Vaccines Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
Porter’s Five Forces
The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Viral Vector Vaccines Market, gauge the attractiveness of a certain sector, and assess investment possibilities.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| STUDY PERIOD | 2020-2030 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2030 |
| HISTORICAL PERIOD | 2020-2022 |
| UNIT | Value (USD Billion) |
| KEY COMPANIES PROFILED | Advanced Bioscience Laboratories, C.H. Boehringer Sohn AG & Ko, Sanofi S.A., Brammer Bio, LLC, Creative Biogene, GE Healthcare, and Pfizer Inc. |
| SEGMENTS COVERED | By Type, By Disease, By End-Users, And By Geography. |
| CUSTOMIZATION SCOPE | Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF THE GLOBAL VIRAL VECTOR VACCINES MARKET
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations
2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
2.1 Data Mining
2.2 Data Triangulation
2.3 Bottom-Up Approach
2.4 Top-Down Approach
2.5 Research Flow
2.6 Key Insights from Industry Experts
2.7 Data Sources
3 EXECUTIVE SUMMARY
3.1 Market Overview
3.2 Ecology Mapping
3.3 Absolute Market Opportunity
3.4 Market Attractiveness
3.5 Global Viral Vector Vaccines Market Geographical Analysis (CAGR %)
3.6 Global Viral Vector Vaccines Market, By Type (USD Million)
3.7 Global Viral Vector Vaccines Market, By Disease (USD Million)
3.8 Global Viral Vector Vaccines Market, By End-Users(USD Million)
3.9 Future Market Opportunities
3.10 Global Market Split
3.11 Product Life Line
4 GLOBAL VIRAL VECTOR VACCINES MARKET OUTLOOK
4.1 Global Viral Vector Vaccines Evolution
4.2 Drivers
4.2.1 Driver 1
4.2.2 Driver 2
4.3 Restraints
4.3.1 Restraint 1
4.3.2 Restraint 2
4.4 Opportunities
4.4.1 Opportunity 1
4.4.2 Opportunity 2
4.5 Porters Five Force Model
4.6 Value Chain Analysis
4.7 Pricing Analysis
4.8 Macroeconomic Analysis
5 GLOBAL VIRAL VECTOR VACCINES MARKET, BY TYPE
5.1 Overview
5.2 Adeno-associated virus (AAV)
5.3 Lentivirus
5.4 Adenovirus
5.5 Retrovirus
5.6 Others
6 GLOBAL VIRAL VECTOR VACCINES MARKET, BY DISEASE
6.1 Overview
6.2 Cancer
6.3 Genetic Disorders
6.4 Infectious Diseases
6.5 Others
7 GLOBAL VIRAL VECTOR VACCINES MARKET, BY END-USERS
7.1 Overview
7.2 Research Institutes
7.3 Pharmaceutical and Biopharmaceutical Companies
8 GLOBAL VIRAL VECTOR VACCINES MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Rest of Middle-East and Africa
9 GLOBAL VIRAL VECTOR VACCINES MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Ranking
9.3 Key Developments
9.4 Company Regional Footprint
9.5 Company Industry Footprint
9.6 ACE Matrix
10 COMPANY PROFILES
10.1 Advanced Bioscience Laboratories
10.1.1 Company Overview
10.1.2 Company Insights
10.1.3 Product Benchmarking
10.1.4 Key Development
10.1.5 Winning Imperatives
10.1.6 Current Focus & Strategies
10.1.7 Threat from Competition
10.1.8 SWOT Analysis
10.2 C.H. Boehringer Sohn AG & Ko
10.2.1 Company Overview
10.2.2 Company Insights
10.2.3 Product Benchmarking
10.2.4 Key Development
10.2.5 Winning Imperatives
10.2.6 Current Focus & Strategies
10.2.7 Threat from Competition
10.2.8 SWOT Analysis
10.3 Sanofi S.A.
10.3.1 Company Overview
10.3.2 Company Insights
10.3.3 Product Benchmarking
10.3.4 Key Development
10.3.5 Winning Imperatives
10.3.6 Current Focus & Strategies
10.3.7 Threat from Competition
10.3.8 SWOT Analysis
10.4 Brammer Bio, LLC
10.4.1 Company Overview
10.4.2 Company Insights
10.4.3 Product Benchmarking
10.4.4 Key Development
10.4.5 Winning Imperatives
10.4.6 Current Focus & Strategies
10.4.7 Threat from Competition
10.4.8 SWOT Analysis
10.5 Creative Biogene
10.5.1 Company Overview
10.5.2 Company Insights
10.5.3 Product Benchmarking
10.5.4 Key Development
10.5.5 Winning Imperatives
10.5.6 Current Focus & Strategies
10.5.7 Threat from Competition
10.5.8 SWOT Analysis
10.6 GE Healthcare
10.6.1 Company Overview
10.6.2 Company Insights
10.6.3 Product Benchmarking
10.6.4 Key Development
10.6.5 Winning Imperatives
10.6.6 Current Focus & Strategies
10.6.7 Threat from Competition
10.6.8 SWOT Analysis
10.7 Pfizer Inc
10.7.1 Company Overview
10.7.2 Company Insights
10.7.3 Product Benchmarking
10.7.4 Key Development
10.7.5 Winning Imperatives
10.7.6 Current Focus & Strategies
10.7.7 Threat from Competition
10.7.8 SWOT Analysis
10 VERIFIED MARKET INTELLIGENCE
10.1 About Verified Market Intelligence
10.2 Dynamic Data Visualization
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
